Hemojuvelin N-terminal mutants reach the plasma membrane but do not activate the hepcidin response
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hemojuvelin is a glycosylphosphatidylinositol-anchored protein, expressed in liver, skeletal muscle and heart. As a co-receptor of bone morphogenetic protein, membrane hemojuvelin positively modulates the iron regulator hepcidin. Mutations of the gene encoding for hemojuvelin cause juvenile hemochromatosis, characterized by hepcidin deficiency and severe iron overload. We have previously shown that several hemojuvelin variants do not efficiently reach the plasma membrane, whereas a few N-terminal mutants localize to the plasma membrane. DESIGN AND METHODS: We studied hemojuvelin mutants of N-terminus (C80R, S85P, G99V, DeltaRGD) and GDPH-consensus site for autoproteolysis (A168D, F170S, D172E) transiently expressed in HeLa cells, using electron microscopy, morphometric analysis and binding assays at different time points. Hepcidin activation by wild-type and mutant forms of hemojuvelin was assessed in Hep3B cells transfected with a hepcidin-promoter luciferase-reporter construct. RESULTS: S85P, G99V and DeltaRGD were localized to plasma membrane 36 hours after transfection, but less efficiently exported than the wild-type protein at earlier (24-30 hours) times. Morphometric analysis clearly documented delayed export and endoplasmic reticulum retention of G99V. C80R was exported without delay. GDPH variants were partially retained in the endoplasmic reticulum and Golgi apparatus, but showed impaired plasma membrane localization. In the hepcidin promoter assay only wild type hemojuvelin was able to activate hepcidin. CONCLUSIONS: The delayed export and retention in the endoplasmic reticulum of some N-terminal mutants could contribute to the pathogenesis of juvenile hemochromatosis, reducing a prompt response of bone morphogenetic protein. However, independently of their plasma membrane export, all hemojuvelin mutants tested showed no or minimal hepcidin activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 2×
“Membrane-HJV (m-HJV) is a co-receptor for bone morphogenetic protein (BMP), which participates in the activation of hepcidin transcription.(8,9) HJV also exists as a soluble protein (s-HJV) produced by furin cleavage and secreted into the extracellular environment.”
BackgroundMutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L. E., Franchini, P. L., Dubé, M.-P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1274 · Cited by 974
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860 · cited 1×
“Patients with juvenile hemochromatosis caused by HJV mutations (type 2A) share the same phenotype as that of patients with mutations that disrupt the hepcidin gene (HAMP, type 2B).(2) The central role of HJV in body iron homeostasis is supported by the evidence that Hjv knockout mice (Hjv mice) show severe suppression…”
BackgroundSelf-citationA role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614
Goswami, T., & Andrews, N. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600197200 · Cited by 352
Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
Silvestri, L., Pagani, A., & Camaschella, C. (2008) · Blood · doi:10.1182/blood-2007-07-100677 · Cited by 311
Self-citationLin, L., Valore, E. V., Nemeth, E., Goodnough, J. B., Gabayan, V., & Ganz, T. (2007) · Blood · doi:10.1182/blood-2007-04-087593 · Cited by 267 · cited 2×
“The in vivo hepcidin response to an acute administration of iron by injection or ingestion is rapid and proportional to the rise of transferrin saturation.(19) HJV mutants that do not efficiently reach the plasma membrane cannot interact correctly with BMP/BMPreceptor complexes on the cell surface.”
BackgroundCompetitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
Lin, L., Goldberg, Y. P., & Ganz, T. (2005) · Blood · doi:10.1182/blood-2005-05-1845 · Cited by 241 · cited 1×
“s-HJV acts as an antagonist in the hepcidin activation pathway, sequestering BMP and interrupting their signaling.(10) Large amounts of s-HJV are released into cellular media in conditions of iron deficiency(6) and this soluble protein is reduced in conditions of iron overload.”
BackgroundSilvestri, L., Pagani, A., Fazi, C., Gerardi, G., Levi, S., Arosio, P., & Camaschella, C. (2007) · Blood · doi:10.1182/blood-2006-08-041004 · Cited by 84 · cited 16×
“Morphometric analysis showed that D172E, like F170S, although partially retained in the endoplasmic reticulum, is found in the Golgi apparatus.(11) Perhaps these mutants are confined in the Golgi apparatus because of their misfolded conformation, and could then be addressed to a degradation system, as shown for other…”
BackgroundMethodSelf-citation
Cited by
Silvestri, L., Pagani, A., Nai, A., De Domenico, I., Kaplan, J., & Camaschella, C. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.012 · Cited by 555
Self-citationNai, A., Pagani, A., Silvestri, L., Campostrini, N., Corbella, M., Girelli, D., Traglia, M., Toniolo, D., & Camaschella, C. (2011) · Blood · doi:10.1182/blood-2011-06-364034 · Cited by 113
Self-citationRepulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein
Healey, E. G., Bishop, B., Elegheert, J., Bell, C. H., Padilla-Parra, S., & Siebold, C. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3016 · Cited by 112
Genetic mechanisms and modifying factors in hereditary hemochromatosis
Weiss, G. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.201 · Cited by 82
Colucci, S., Pagani, A., Pettinato, M., Artuso, I., Nai, A., Camaschella, C., & Silvestri, L. (2017) · Blood · doi:10.1182/blood-2017-04-780692 · Cited by 62
“with both BRE-Luc (supplemental Figure 1A) and HAMP-Luc (supplemental Figure 1B) vectors, with the latter expressing the luciferase under the control of the hepcidin promoter.(22) In addition, GPI-1046 upregulates endogenous hepcidin (supplemental Figure 1C) and Id1 (supplemental Figure 1D) expression in murine primar…”
BackgroundSelf-citation
Metadata
- Authors
- Pagani, A., Silvestri, L., Nai, A., & Camaschella, C.
- Venue
- Haematologica
- Published
- 2008-10-01
- Volume
- 93
- Issue
- 10
- Pages
- 1466-1472
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2127121874
- Cited by
- 31
- References
- 9
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hemojuvelin N-terminal mutants reach the plasma membrane but do not activate the hepcidin response. https://app.cochat.ai/papers/10.3324/haematol.12508
- The paper
- Pagani, A., Silvestri, L., Nai, A., & Camaschella, C. (2008). Hemojuvelin N-terminal mutants reach the plasma membrane but do not activate the hepcidin response. Haematologica. https://doi.org/10.3324/haematol.12508
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.